Condition
Immune Checkpoint Blockade clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Immune Checkpoint Blockade clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Zusanli (ST36) electroacupuncture plus immunotherapy in NSCLC before surgery
This trial tests whether adding electroacupuncture at ST36 to standard neoadjuvant immunotherapy helps patients with NSCLC better respond to treatment.
-
Low-dose intestinal radiation plus immunotherapy for immune-resistant metastatic solid cancers
This trial tests whether giving small doses of radiation to the intestine together with PD‑1/PD‑L1 immunotherapy can help people whose metastatic solid tumors have stopped responding to checkpoint inhibitors.
Related topics
Quick answers
How many Immune Checkpoint Blockade clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.